Deck Bio is a preclinical biotechnology company developing next-generation T cell engagers for the treatment of solid tumors. The company’s platform is built around multi-pMHC targeting: a single drug designed to recognize multiple cancer-specific targets simultaneously, maintaining potency despite... Read more
This company has no teams yet
This company has no offices yet